<p>The present invention is directed to a method of enhancing TGF-ß signaling in a subject comprising administering to said subject a clathrin-dependent endocytosis inhibitor in an amount sufficient to enhance TGF- ß signaling. In another aspect, the invention is directed to a method of treating a condition associated with decreased TGF- ß signaling in a patient in need thereof comprising administering to said patient a clathrin-dependent endocytosis inhibitor in a therapeutically effective amount.</p>
申请公布号
WO2010033507(A1)
申请公布日期
2010.03.25
申请号
WO2009US56994
申请日期
2009.09.15
申请人
ST. LOUIS UNIVERSITY;AUXAGEN, INC.;HUANG, JUNG, SAN;HUANG, SHUAN, SHIAN